Regeneron Pharmaceuticals (REGN) Assets Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.12% |
| Dec 31, 2025 | 18.77% |
| Sep 30, 2025 | 20.09% |
| Jun 30, 2025 | 21.51% |
| Mar 31, 2025 | 18.96% |
| Dec 31, 2024 | 20.59% |
| Sep 30, 2024 | 21.85% |
| Jun 30, 2024 | 22.33% |
| Mar 31, 2024 | 21.74% |
| Dec 31, 2023 | 23.03% |
| Sep 30, 2023 | 24.38% |
| Jun 30, 2023 | 25.23% |
| Mar 31, 2023 | 26.25% |
| Dec 31, 2022 | 27.23% |
| Sep 30, 2022 | 26.04% |
| Jun 30, 2022 | 27.40% |
| Mar 31, 2022 | 27.51% |
| Dec 31, 2021 | 29.54% |
| Sep 30, 2021 | 28.23% |
| Jun 30, 2021 | 28.20% |
| Mar 31, 2021 | 24.66% |
| Dec 31, 2020 | 25.07% |
| Sep 30, 2020 | 25.42% |
| Jun 30, 2020 | 26.09% |
| Mar 31, 2020 | 30.28% |
| Dec 31, 2019 | 31.00% |
| Sep 30, 2019 | 30.10% |
| Jun 30, 2019 | 30.68% |
| Mar 31, 2019 | 31.57% |
| Dec 31, 2018 | 31.79% |
| Sep 30, 2018 | 32.55% |
| Jun 30, 2018 | 33.15% |
| Mar 31, 2018 | 32.72% |
| Dec 31, 2017 | 33.32% |
| Sep 30, 2017 | 39.27% |
| Jun 30, 2017 | 40.94% |
| Mar 31, 2017 | 42.08% |
| Dec 31, 2016 | 39.42% |
| Sep 30, 2016 | 47.35% |
| Jun 30, 2016 | 42.75% |
| Mar 31, 2016 | 40.61% |
| Dec 31, 2015 | 38.78% |
| Sep 30, 2015 | 40.63% |
| Jun 30, 2015 | 41.76% |
| Dec 31, 2014 | 38.94% |